Action Plan for Liver Disease Research
Introduction

Introduction and Mission Guiding Principles Work in Progress Topic Areas *Drafts available* Participants Comments

Liver disease is an important cause of morbidity and mortality in the United States, affecting persons of all ages, but most frequently individuals in the productive years of life, between the ages of 40 and 60 years. Liver disease also disproportionately affects minority individuals and the economically disadvantaged. Medical research on liver disease is critically important and further progress in research promises to bring under control the major toll of liver disease on human health and well-being. Indeed, the last 25 years of medical research in liver disease has resulted in major improvements in the survival and quality-of-life of patients with liver disease. The next 25 years should bring even more profound and important changes.

To address the burden of liver diseases in the United States, the National Institutes of Health is developing an Action Plan for Liver Disease Research.

Home || Welcome || Health Information || Research Funding Opportunities || Clinical Research || NIDDK Laboratories || Reports, Testimony & Plans || Site Map || FAQs || Contact NIDDK || Search

Director: Dr. Allen Spiegel || Contact NIDDK
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health, Bethesda, MD, USA. General inquiries may be addressed to Office of Communications and Public Liaison, NIDDK, NIH, Building 31, room 9A04 Center Drive, MSC 2560, Bethesda, MD 20892-2560, USA. || Privacy || Disclaimer || Copyright || Credits || Accessibility